GB2095

Overview

GB2095 is an orally active and selective galectin-3 inhibitor. GB2095 shows superior selectivity for both human ( K D = 0.036 μM) and mouse galectin-3 ( K D = 0.35 μM) over other galectins (such as h-Gal-1/4N/4C/8N/8C/9N/9C and m-galectin-1). GB2095 inhibits tumor growth in syngeneic mouse models of breast and melanoma cancers. GB2095 can be used for breast and melanoma cancer research.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > Galectin

Product Information

• Catalog No.: HY-170510
• CAS No.: 2574415-75-9
• Molecular Formula: C20H17BrClF2N3O4S
• Molecular Weight: 548.79
• Purity: 98.92%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.5 mg/mL (4.56 mM); Clear solution
• Availability: In-stock

Source

Original product source